Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
•This ESMO Clinical Practice Guideline provides key recommendations for managing biliary tract cancer.•The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.•A treatment and management algorithm for locoregional and advanced/metastatic disease...
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2023-02, Vol.34 (2), p.127-140 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 140 |
|---|---|
| container_issue | 2 |
| container_start_page | 127 |
| container_title | Annals of oncology |
| container_volume | 34 |
| creator | Vogel, A. Bridgewater, J. Edeline, J. Kelley, R.K. Klümpen, H.J. Malka, D. Primrose, J.N. Rimassa, L. Stenzinger, A. Valle, J.W. Ducreux, M. |
| description | •This ESMO Clinical Practice Guideline provides key recommendations for managing biliary tract cancer.•The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.•A treatment and management algorithm for locoregional and advanced/metastatic disease is provided.•ESCAT scores are given to describe the evidence level for genomic alterations as biomarkers for using targeted therapies.•Recommendations are based on available scientific data and the authors’ collective expert opinion. |
| doi_str_mv | 10.1016/j.annonc.2022.10.506 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03888631v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753422046993</els_id><sourcerecordid>2736304891</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-871ecc0bdf1042033726ad23bd1dc84910ba14d1d6e46fd9d5af98b4ba2744733</originalsourceid><addsrcrecordid>eNp9kV9rFDEUxYNY7Fr9BiJ5tOCs-beZjA9Cu9S2sFJBfZSQSe5olmyyJjMVv70ZpvbRp5Bzf_fe5ByEXlGypoTKd_u1iTFFu2aEsSqtN0Q-QSu6kV2jiKBP0Yp0jDfthotT9LyUPSFEdqx7hk655C1jiq7Q90sfvMl_8JiNHbE10UJ-j6--fLrD2-Cjtybgz3PNW8DXk3dQVcBDyth58yOm4svb2g1mPEAcsYmuFkNIv5vp-AKdDCYUePlwnqFvH6--bm-a3d317fZi11gh2NioloK1pHcDJYIRXh8njWO8d9RZJTpKekNFvUgQcnCd25ihU73oDWuFaDk_Q-fL3J8m6GP2h_ojnYzXNxc7PWuEK6Ukp_e0sm8W9pjTrwnKqA--WAjBREhT0ayt7hChuhkVC2pzKiXD8DibEj2HoPd6CUHPIcxqDaG2vX7YMPUHcI9N_1yvwIcFgOrJvYesi_VQnXc-gx21S_7_G_4CGvmY4A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2736304891</pqid></control><display><type>article</type><title>Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Vogel, A. ; Bridgewater, J. ; Edeline, J. ; Kelley, R.K. ; Klümpen, H.J. ; Malka, D. ; Primrose, J.N. ; Rimassa, L. ; Stenzinger, A. ; Valle, J.W. ; Ducreux, M.</creator><creatorcontrib>Vogel, A. ; Bridgewater, J. ; Edeline, J. ; Kelley, R.K. ; Klümpen, H.J. ; Malka, D. ; Primrose, J.N. ; Rimassa, L. ; Stenzinger, A. ; Valle, J.W. ; Ducreux, M. ; ESMO Guidelines Committee ; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org</creatorcontrib><description>•This ESMO Clinical Practice Guideline provides key recommendations for managing biliary tract cancer.•The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.•A treatment and management algorithm for locoregional and advanced/metastatic disease is provided.•ESCAT scores are given to describe the evidence level for genomic alterations as biomarkers for using targeted therapies.•Recommendations are based on available scientific data and the authors’ collective expert opinion.</description><identifier>ISSN: 0923-7534</identifier><identifier>ISSN: 1569-8041</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1016/j.annonc.2022.10.506</identifier><identifier>PMID: 36372281</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Bile Duct Neoplasms ; Bile Ducts, Intrahepatic ; Biliary Tract Neoplasms - diagnosis ; Biliary Tract Neoplasms - therapy ; Cancer ; Cholangiocarcinoma ; diagnosis ; follow-up ; Follow-Up Studies ; gallbladder cancer ; Gallbladder Neoplasms ; Humans ; Life Sciences ; precision medicine ; treatment</subject><ispartof>Annals of oncology, 2023-02, Vol.34 (2), p.127-140</ispartof><rights>2022 European Society for Medical Oncology</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-871ecc0bdf1042033726ad23bd1dc84910ba14d1d6e46fd9d5af98b4ba2744733</citedby><cites>FETCH-LOGICAL-c442t-871ecc0bdf1042033726ad23bd1dc84910ba14d1d6e46fd9d5af98b4ba2744733</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36372281$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03888631$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Vogel, A.</creatorcontrib><creatorcontrib>Bridgewater, J.</creatorcontrib><creatorcontrib>Edeline, J.</creatorcontrib><creatorcontrib>Kelley, R.K.</creatorcontrib><creatorcontrib>Klümpen, H.J.</creatorcontrib><creatorcontrib>Malka, D.</creatorcontrib><creatorcontrib>Primrose, J.N.</creatorcontrib><creatorcontrib>Rimassa, L.</creatorcontrib><creatorcontrib>Stenzinger, A.</creatorcontrib><creatorcontrib>Valle, J.W.</creatorcontrib><creatorcontrib>Ducreux, M.</creatorcontrib><creatorcontrib>ESMO Guidelines Committee</creatorcontrib><creatorcontrib>ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org</creatorcontrib><title>Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><description>•This ESMO Clinical Practice Guideline provides key recommendations for managing biliary tract cancer.•The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.•A treatment and management algorithm for locoregional and advanced/metastatic disease is provided.•ESCAT scores are given to describe the evidence level for genomic alterations as biomarkers for using targeted therapies.•Recommendations are based on available scientific data and the authors’ collective expert opinion.</description><subject>Bile Duct Neoplasms</subject><subject>Bile Ducts, Intrahepatic</subject><subject>Biliary Tract Neoplasms - diagnosis</subject><subject>Biliary Tract Neoplasms - therapy</subject><subject>Cancer</subject><subject>Cholangiocarcinoma</subject><subject>diagnosis</subject><subject>follow-up</subject><subject>Follow-Up Studies</subject><subject>gallbladder cancer</subject><subject>Gallbladder Neoplasms</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>precision medicine</subject><subject>treatment</subject><issn>0923-7534</issn><issn>1569-8041</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV9rFDEUxYNY7Fr9BiJ5tOCs-beZjA9Cu9S2sFJBfZSQSe5olmyyJjMVv70ZpvbRp5Bzf_fe5ByEXlGypoTKd_u1iTFFu2aEsSqtN0Q-QSu6kV2jiKBP0Yp0jDfthotT9LyUPSFEdqx7hk655C1jiq7Q90sfvMl_8JiNHbE10UJ-j6--fLrD2-Cjtybgz3PNW8DXk3dQVcBDyth58yOm4svb2g1mPEAcsYmuFkNIv5vp-AKdDCYUePlwnqFvH6--bm-a3d317fZi11gh2NioloK1pHcDJYIRXh8njWO8d9RZJTpKekNFvUgQcnCd25ihU73oDWuFaDk_Q-fL3J8m6GP2h_ojnYzXNxc7PWuEK6Ukp_e0sm8W9pjTrwnKqA--WAjBREhT0ayt7hChuhkVC2pzKiXD8DibEj2HoPd6CUHPIcxqDaG2vX7YMPUHcI9N_1yvwIcFgOrJvYesi_VQnXc-gx21S_7_G_4CGvmY4A</recordid><startdate>202302</startdate><enddate>202302</enddate><creator>Vogel, A.</creator><creator>Bridgewater, J.</creator><creator>Edeline, J.</creator><creator>Kelley, R.K.</creator><creator>Klümpen, H.J.</creator><creator>Malka, D.</creator><creator>Primrose, J.N.</creator><creator>Rimassa, L.</creator><creator>Stenzinger, A.</creator><creator>Valle, J.W.</creator><creator>Ducreux, M.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope></search><sort><creationdate>202302</creationdate><title>Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up</title><author>Vogel, A. ; Bridgewater, J. ; Edeline, J. ; Kelley, R.K. ; Klümpen, H.J. ; Malka, D. ; Primrose, J.N. ; Rimassa, L. ; Stenzinger, A. ; Valle, J.W. ; Ducreux, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-871ecc0bdf1042033726ad23bd1dc84910ba14d1d6e46fd9d5af98b4ba2744733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Bile Duct Neoplasms</topic><topic>Bile Ducts, Intrahepatic</topic><topic>Biliary Tract Neoplasms - diagnosis</topic><topic>Biliary Tract Neoplasms - therapy</topic><topic>Cancer</topic><topic>Cholangiocarcinoma</topic><topic>diagnosis</topic><topic>follow-up</topic><topic>Follow-Up Studies</topic><topic>gallbladder cancer</topic><topic>Gallbladder Neoplasms</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>precision medicine</topic><topic>treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vogel, A.</creatorcontrib><creatorcontrib>Bridgewater, J.</creatorcontrib><creatorcontrib>Edeline, J.</creatorcontrib><creatorcontrib>Kelley, R.K.</creatorcontrib><creatorcontrib>Klümpen, H.J.</creatorcontrib><creatorcontrib>Malka, D.</creatorcontrib><creatorcontrib>Primrose, J.N.</creatorcontrib><creatorcontrib>Rimassa, L.</creatorcontrib><creatorcontrib>Stenzinger, A.</creatorcontrib><creatorcontrib>Valle, J.W.</creatorcontrib><creatorcontrib>Ducreux, M.</creatorcontrib><creatorcontrib>ESMO Guidelines Committee</creatorcontrib><creatorcontrib>ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vogel, A.</au><au>Bridgewater, J.</au><au>Edeline, J.</au><au>Kelley, R.K.</au><au>Klümpen, H.J.</au><au>Malka, D.</au><au>Primrose, J.N.</au><au>Rimassa, L.</au><au>Stenzinger, A.</au><au>Valle, J.W.</au><au>Ducreux, M.</au><aucorp>ESMO Guidelines Committee</aucorp><aucorp>ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2023-02</date><risdate>2023</risdate><volume>34</volume><issue>2</issue><spage>127</spage><epage>140</epage><pages>127-140</pages><issn>0923-7534</issn><issn>1569-8041</issn><eissn>1569-8041</eissn><abstract>•This ESMO Clinical Practice Guideline provides key recommendations for managing biliary tract cancer.•The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.•A treatment and management algorithm for locoregional and advanced/metastatic disease is provided.•ESCAT scores are given to describe the evidence level for genomic alterations as biomarkers for using targeted therapies.•Recommendations are based on available scientific data and the authors’ collective expert opinion.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>36372281</pmid><doi>10.1016/j.annonc.2022.10.506</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2023-02, Vol.34 (2), p.127-140 |
| issn | 0923-7534 1569-8041 1569-8041 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_03888631v1 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Bile Duct Neoplasms Bile Ducts, Intrahepatic Biliary Tract Neoplasms - diagnosis Biliary Tract Neoplasms - therapy Cancer Cholangiocarcinoma diagnosis follow-up Follow-Up Studies gallbladder cancer Gallbladder Neoplasms Humans Life Sciences precision medicine treatment |
| title | Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T21%3A04%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biliary%20tract%20cancer:%20ESMO%20Clinical%20Practice%20Guideline%20for%20diagnosis,%20treatment%20and%20follow-up&rft.jtitle=Annals%20of%20oncology&rft.au=Vogel,%20A.&rft.aucorp=ESMO%20Guidelines%20Committee&rft.date=2023-02&rft.volume=34&rft.issue=2&rft.spage=127&rft.epage=140&rft.pages=127-140&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1016/j.annonc.2022.10.506&rft_dat=%3Cproquest_hal_p%3E2736304891%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2736304891&rft_id=info:pmid/36372281&rft_els_id=S0923753422046993&rfr_iscdi=true |